Histone deacetylase 1 mRNA expression in lung cancer

Lung Cancer

Volumn 46, Issue 2, 2004, Pages 171-178

  Sasaki, Hidefumi ^a   Moriyama, Satoru ^a   Nakashima, Yoshiaki ^a   Kobayashi, Yoshihiro ^a   Kiriyama, Masanobu ^a   Fukai, Ichiro ^a   Yamakawa, Yosuke ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

HDAC1; LightCycler; Lung cancer; MTA1; Progression

Indexed keywords

HISTONE DEACETYLASE; MESSENGER RNA; METASTATIC ASSOCIATED PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HISTONE DEACETYLASES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 4944223370     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.03.021     Document Type: Article

References (36)

1. Ginsberg RJ, Kris K, Armstrong G. Cancer of the lung. In: Principles and Practice of Oncology. Fourth ed. Lippincott:Philadelphia;1993. pp. 673-682.
2. Yasuda K., Ayabe H., Ide H., Uchida Y. On behalf of the Japanese Association for thoracic surgery: thoracic and cardiovascular surgery in Japan during 1998. Annual report by the Japanese association for thoracic surgery. Jpn. J. Cardiothorac. Surg. 48:1998;401-415
3. Postus P.E. On behalf of the Lung Cancer Cooperative Group of the EORTC The experience of the lung cancer cooperative group of the European Organization for Research and Treatment of Cancer. Chest Supple. 113:1997;28S-31S
4. Kuo M.H., Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 20:1998;615-626
5. Hassig C., Schreiber S. Nuclear histone acetylase and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1:1997;300-308
6. Turner B.M. Histone acetylation and control of gene expression. J. Cell Sci. 99:1991;13-20
7. Petrij F., Giles R.H., Dauwerse H.G., Saris J.J., Hennekam R.C., Masuno M., et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 376:1995;348-351
8. Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.E., Lee S.W., et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7:2001;437-443
9. Choi J.-H., Kwon H.J., Yonn B-I, Kim J.-H., Han S.U., Joo H.J., et al. Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn. J. Cancer Res. 92:2001;1300-1304
10. Toh Y., Yamamoto M., Endo K., Ikeda Y., Baba H., Kohnoe S., et al. Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol. Rep. 10:2003;333-338
11. Yoshida M., Shimazu T., Matsuyama A. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets. Prog. Cell Cycler Res. 5:2003;269-278
12. Arts J., de Schepper S., Xan Emelen K. Histone deacetylase inhibitors: from chromatin remodeling to experimental cancer therapeutics. Curr. Med. Chem. 10:2003;2343-2350
13. Zhu W.G., Otterson G.A. The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. Curr. Med. Chem. Anti-Cancer Agents. 3:2003;187-199
14. Rosato R.R., Grant S. Histone deacetylase inhibitors in cancer therapy. Cancer Biol. Ther. 2:2003;30-37
15. Mazumdar A., Wang R.A., Mishra S.K., Adam L., Bagheri-Yamand R., Mandal M., et al. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3:2001;30-37
16. Wang S., Yan-Neale Y., Fischer D., Zeremski M., Cai R., Zhu J., et al. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Oncogene. 22:2003;6204-6213
17. Wittwer T., Ririe M., Andrew V., David A., Gungry A., Bali J. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques. 22:1997;176-181
18. Japan Lung Cancer Society, General Rule for Clinical and Pathological Record of Lung Cancer. Fifth ed. The Japan Lung Cancer Society, vol. 5;1999. pp. 1-177.
19. Sasaki H., Moriyama S., Nakashima Y., Kobayashi Y., Yukiue H., Kaji M., et al. Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer. 35:2002;149-154
20. Vigushin D.M., Coombers R.C. Histone deacetylase inhibitor in cancer treatment. in the regulation of apoptosis and in cell cycle control. Anticancer Drugs. 13:2002;1-13
21. Marks P.A., Richon V.M., Breslow R., Rifkind R.A. Histon deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13:2001;477-483
22. Marks P.A., Rifkind R.A., Richon V.M., Breslow R., Miller T., Kelly W.K. Histone deacetylase and cancer. Nat. Rev. Cancer. 1:2001;194-202
23. Rosato R.R., Wang Z., Gopalkrishnan R.V., Fisher P.B., Grant S. Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21/WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937). Int. J. Oncol. 19:2001;181-191
24. Ruefli A.A., Ausserlechner M.J., Bernhard D., Sutton V.R., Tainton K.M., Kofler R., et al. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxgen species. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10833-10838
25. Kwon S.H., Ahn S.H., Kim Y.K., Bae G.U., Yoon J.W., Hong S., et al. Apicidin, a histone deacetylase inhibitor induces apoptosis and Fas/Fas ligand expession in human acute promyelocytic leukemia cells. J. Biol. Chem. 277:2002;2073-2080
26. Herold C., Ganslmayer M., Ocker M., Hermann M., Geerts A., Hahn E.G., et al. The histone-deacetylase inhibitor trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J. Hepatol. 36:2002;233-240
27. Selvakumaran M., Reed J.C., Liebermann D., Hoffman B. Progression of the myeloid differentiation program is dominant to transforming growth factor-β1-induced apoptosis in M1 myeloid leukemic cells. Blood. 84:1994;1036-1042
28. Yu X., Guo Z.S., Marcu M.G., Neckers L., Nguyen D.M., Chen G.A., et al. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J. Natl. Cancer Inst. 94:2002;504-513
29. Yao Y.-L., Yang W.-M. The metastasis-associated protein 1 and 2 form distinct protein complexes with histone deacetylase activity. J. Biol. Chem. 43:2003;42560-42568
30. Toh Y., Pencil S.D., Nicolson G.L. A novel candidate metastasis- associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression and protein analyses. J. Biol. Chem. 269:1994;22958-22963
31. Toh Y., Oki E., Oda S., Tokunaga E., Ohno S., Maehara Y., et al. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int. J. Cancer. 74:1997;459-463
32. Toh Y., Kuwano H., Mori M., Nicolson G.L., Sugimachi K. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br. J. Cancer. 79:1999;1723-1726
33. Sasaki H., Yukiue H., Kobayashi Y., Nakashima Y., Kaji M., Fukai I., et al. Expression of the MTA1 mRNA in thymoma patients. Cancer Lett. 174:2001;159-163
34. Xue Y., Wong J., Moreno G.T., Young M.K., Cote J., Wang W. NURD a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell. 2:1998;851-861
35. Mazumdar A., Wang R.A., Mishra S.K., Adam L., Bagheri-Yarman R., Mandal M., et al. Transcriptional repressor of oestrogen receptor by metastasis-associated protein corepressor. Nat. Cell Biol. 3:2001;30-37
36. Talukder A.H., Mishra S.K., Mandal M., Balasenthil S., Mehta S., Sahin A.A., et al. MTA1 interact with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor and regulates estrogen receptor transactivation functions. J. Biol. Chem. 278:2003;11676-11685